Safety profile of sibutramine to be independently determined in March, KFDA says

Published: 2010-02-08 07:00:00
Updated: 2010-02-08 07:00:00
In view of latest studies suggesting higher risk of heart diseases, the Korea’s health watchdog will independently assess the safety profile of sibutramine next month, apart from the decisions in foreign countries.

The Korea Food and Drug Administration said it has already request Abbott Labor...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.